Martin Faehling

5PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 25, 2026
Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from Germany.

|Apr 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.

Martin Faehling, Sabine Fallscheer, Birgit Schwenk

|Mar 31, 2022
Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP).

Martin Faehling, Hanno Witte, Martin Sebastian

|Aug 01, 2018
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.

Martin Faehling, Birgit Schwenk, Sebastian Kramberg

|Apr 25, 2018
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).

M Faehling, J Achenbach, P Staib

Pageof 1

Frequent Collaborators

2 joint publications

Wolfgang M Brückl

1 joint publications

Jörn Sträter

1 joint publications

Claudia Lengerke

1 joint publications

Petros Christopoulos